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EFFECTS OF CYTOKINES ON PITUITARY 
ß-ENDORPHIN AND ADRENAL 
CORTICOSTERONE RELEASE IN VITRO
Mike J. M. van der Meer,1 Ad R. M. M. Hermus,1 Gerard J. Pesman,2 C. G. J. (Fred) Sweep2
We investigated the effects of recombinant human IL-la, -lß, -2, -6 and TNF on the in vitro 
secretion of ß-endorphin-immunoreactivity (ßE-IR) by the rat anterior and neurointermedi- 
ate lobes (AL and NIL, respectively) and of B by the rat adrenal gland. Isolated AL and NIL 
cells were incubated for 2 h with cytokines (1 pg/ml-1 (.ig/rnl), CRH (5.10 10 M) or with 
cytokines in combination with CRH (AL cells), isolated adrenal cells were incubated for 
2 h with cytokines, ACTH (25 pg/ml) or with cytokines in combination with ACTH. 
Furthermore, AL, NIL and adrenal tissue fragments were superfused for 30 or 60 min with 
cytokines (10 and/or 100 ng/ml). Incubation of AL, NIL and adrenal cells and superfusion of 
these tissues with cytokines had no significant effect on ßE-IR and B release. However, there 
are some exceptions: incubation of AL cells with IL-2 increased CRH-induced ßE-IR 
release, incubation of NIL cells with IL-2 induced an increase of basal ßE-IR release, ACTH- 
induced B secretion was reduced after co-incubation of adrenal cells with TNF and after pro­
longed (6 h) superfusion of adrenal tissue with TNF, and finally, prolonged (6 h) superfusion 
of adrenal fragments with IL-lß increased basal B release. Taken together, these data suggest 
that the acute activation of the pituitary-adrenal axis of rats by administration of cytokines 
(at least IL-1, IL-6 and TNF) in vivo is not mediated by a direct action of these cytokines at 
the level of the pituitary and/or adrenal gland.
between the immune system and the (neuro-) Whether IL-1 can directly stimulate ACTH and ß-
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TNF on B release by adrenal cells in vitro only few data
concerning direct effects of IL-1 and other cytokines on 
hormone release by the intermediate lobe of the pitu­
itary gland.
In the light of these controversial data, we system-
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a number of cytokines (IL-la, IL-lß, IL-2, IL-6 and 
TNF) in a broad range of concentrations, on the secre­
tion of ß-endorphin-immunoreactivity (ßE-IR) by the
AL and the NIL of the rat pituitary gland and on the
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secretion of B by the rat adrenal gland. We used two 
supplementary in vitro methods: static incubation of 
freshly prepared cell suspensions and superfusion of the 
tissues.
RESULTS
Cell suspension experiments
A L  cells. Figure 1 shows the effects of incubation of 
freshly isolated AL cells with IL-la, IL-lß, IL-2, IL-6
or TNF alone, or with these cytokines in combination 
with CRH on the release of ßE-IR in vitro. In all exper­
iments incubation of AL cells with 5.10 ui M CRH
induced a significant (P < 0.001) increase in ßE-IR
release ( + 114 ± 8%; n = 38) as compared to ßE-IR 
release by cells incubated with EBSS ' (1.5 ± 0.1 ng/2 h; 
n = 40). Incubation of cells with each of the cytokines 
(1 pg/ml-1 |ig/ml) alone had no significant effect on ßE- 
IR release. Incubation of cells with IL-1 a, -1 ß, -6 or TNF 
in combination with CRH had no significant effect on 
ßE-IR release, whereas incubation of cells with IL-2 in
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1
Release of ßE-IR from isolated rat AL cells in vitro incubated with IL -la , IL-lß, IL-2, IL-fi or TNF 
(1 pg/ml-1 )ig/ml; □ )  or with these cytokines in combination with 5.10 111 M CRI I (■). After 2 h of incubation AL 
cells and medium were separated. ßE-IR content in the medium was measured by a specific RIA. ßE-IR release 
is expressed as percentage (mean + SEM; n -  8) of hormone release by the control group, ND 
***: IL-2 induced a dose-dependent increase of CRH-induced ßE-IR release ( /’ <  0.
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combination with CRH induced a significant (P < 
0.0001) dose-dependent increase in ßE-IR secretion as 
compared to the release by cells incubated with CRH 
alone.
«
NIL cells. The effects of incubation of freshly isolated 
NIL cells with IL-la , IL-lß, IL-2, IL-6 or TNF in con­
centrations of 1 pg/ml-1 jLLg/ml on ßE-IR release are 
listed in Table 1. Incubation of NIL cells with dopamine 
(10~f> M) induced a significant (P <  0.01) reduction of 
ßE-IR release ( -4 3  ± 5%; n = 12) as compared to hor­
mone release by cells incubated with buffer alone (3.0 
± 0.2 ng/2 h; data not shown). Incubation of cells with 
increasing doses of IL-la, IL-lß or IL-6 had no sig-
on ßE-IR release. Although ßE-IRnificant
release by NI L cells in response to incubation with TNF 
at a dose of 10 pg/ml was markedly increased, TNF 
had no significant overall effect on ßE-IR release. 
Incubation with IL-2, however, induced a statistically 
significant (P <  0.001) dose-dependent increase in ßE- 
IR release.
Adrenal cells. Table 2 lists the effects of incubation of 
freshly isolated adrenal cells with IL-la, IL-lß, IL-2,
IL-6 or TNF alone or with these cytokines in combina­
tion with ACTH on corticosterone release. Incubation 
of cells with 25 pg/ml ACTH induced a strong increase 
in B release ( + 1672 ± 71%; n = 53) as compared to B
release by the control group (6.1 ± 0.4 ng/2 h, n 39;
data not shown). Incubation of adrenal cells with 
cytokines (1 pg/ml-1 |ig/ml) alone had no significant
effect on B release. Incubation of cells with IL-la, IL-
i*
lß, IL-2 or IL-6 in combination with ACTH had no 
significant effect on B release as compared to the 
release induced by ACTH alone, whereas TNF induced 
a significant (P <  0.01) dose-dependent decrease of 
the ACTH-induced stimulation of B secretion by rat 
adrenal cells as compared to the stimulation of B secre­
tion by ACTH alone.
Superfusion experiments
A L  tissue. Figure 2 (upper panel) shows the effects of 
superfusion of AL fragments with IL-la, IL-lß, IL-2, 
IL-6, TNF or CRH on ßE-IR release. Superfusion of 
ALs for 30 min with medium containing CRH (5.10" l()M 
respectively 5.10~9 M) induced a rapid, sustained, and
significant {P <  0.001) dose-dependent increase in the
TABLE 1. Effects of incubation of isolated NIL-cells for 2 h with cytokines on the release of ßE-IR a
Cytokine 1 pg/ml 10 pg/m 1 100 pg/ml 1 ng/ml 10 ng/ml 100 ng/ml 1 |ag/ml
IL -la 90.3 ± 7.5 88.3 ± 6.8 108.6 ± 9.5 105.0 ± 12.8 115.1 ± 7.4 95.7 ± 4.3 ND
IL-1 ß 120.0 ± 10.1 106.5 ± 8.3 94.1 ± 5.8 95.3 ± 8.9 92.9 ± 7.3 100.3 ± 10.0 ND
IL-2** 107.3 ± 6.2 102.2 ± 4.4 104.1 ±5.0 102.6 ± 4.3 110.0 ± 5.0 118.0 ±5.1 126.0 ± 6.8
IL-6 96.2 ± 6.2 108.9 ± 14.3 93,2 ± 11.4 83.8 ± 6.4 96.0 ± 6.7 98.1 ± 5.2 97.7 ± 10.3
TNF 114.3 ± 6.5 153.1 ± 7.8 108.2 ± 6.5 115.3 ± 8.6 100.0 ± 8.3 101.4 ±4.8 111. 1 ± 14.8
"ßE-IR release is expressed as percentage (mean ± SEM; n =  8-12) of the basal release. 
** Indicates that there was a significant dose-response relationship (P <  0.001).
TABLE 2. Effects of incubation of isolated adrenal cells for 2 h with cytokines and/or ACTH on B release1
pg/ml 1 pg/ml 10 pg/ml 100 pg/ml 1 ng/ml 10 ng/ml 100 ng/ml 1 |a.g/ml
IL -la 0 91.4 ±9.5 98.9 ± 5.1 100,3 ± 8.3 70.0 ± 17.5 94.7 ± 10.1 107.8 ± 13.0 ND
25 101.5 ± 3.7 101.6 ±5.7 102.6 ± 6.7 104.4 ±5.6 93.7 ± 4.2 88.3 ± 2.7 ND
IL-1 ß 0 85.3 ± 2.9 109.6 ± 8.8 109.6 ± 10.0 91.9 ±9.7 88.5 ± 12.5 112.9 ± 14.2 ND
25 99.2 ± 5.1 98.5 ± 7.5 104.5 ± 5.2 111.0 ± 6.6 99.4 ± 5.3 100.7 ± 3.4 ND
IL-2 0 105.0 ± 11.2 81.3 ± 3.3 90.7 ± 3.1 81.7 ±7.3 88.3 ± 6.4 90.7 ±3.1 88.0 ±5.1
25 106.2 ± 6.3 106.6 ± 6.8 106.2 ±6.1 103.3 ± 5.8 96.4 ± 4.8 108.6 ± 4.6 99.5 ± 8.5
IL-6 0 98.9 ± 12.3 100.0 ± 5.3 123.3 ± 14.5 97.6 ± 13.4 85.9 ± 5.9 96.8 ± 9.0 115.6 ± 10.5
25 98.2 ± 5.1 101.3 ± 6.0 99.0 ±3.7 98.9 ± 3.9 87,0 ± 1.8 106.0 ± 3.9 107.9 ± 6.8
TNF 0 122.2 ± 11.1 110.4 ± 14.2 93.1 ± 10.4 104.6 ± 10.7 104.9 ± 12.1 98.6 ± 14.4 98.6 ± 14.4
25* 107.0 ± 3.6 92.1 ± 5.0 91.0 ±4.9 85.7 ±9.0 80.7 ± 3.8 79.5 ± 9.2 80.0 ± 4.1
HB release is expressed as percentage {mean ± SEM; n =  5 -6 ) of B release by cells incubated with only buffer or with buffer containing 25 pg/ml ACTH respectively. 
* Indicates that there was a significant dose-response relationship (P < 0.01).
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Upper panel: Release of ßE-IR from superfused rat AL tissue in 
vitro. ALs were superfused twice (fr. 7-9 and 17-19; black bars) for 
30 min with medium containing IL - la  ( • ) ,  IL-lß (O), IL-2 (■), IL- 
6 (□) or TNF (A) ( l sl pulse: 10 ng/ml, 2"d pulse: 100 ng/ml) or CRH 
(5.1.0”10 M respectively 5.10 l) M; T). After each pulse, superfusion 
was continued with initial medium. Flow rate was 0,1 ml/min and 10 
min fractions were collected for measurement of ßE-IR content. 
Data are expressed as the mean (+  SEM) ßE-IR release of 4-7 
observations.
Lower panel: Release of B from superfused rat adrenal tissue in 
vitro. Tissue was superfused for 60 min (fr. 11-14; black bar) with
medium containing IL - la  ( • ) ,  IL-lß (O), IL-2 (■ ), IL-6 (□ ), TNI 
(V) (100 ng/ml) or ACTH (125 pg/ml; T). Thereafter superfusion 
was continued with initial medium for 120 min (fr. 15-22). Flow rate 
was 0.1 ml/min and 15 min fractions were collected for B determi­
nation. Data are presented as the mean ( + SEM) B release of six 
observations.
TABLE 3. Effects of superfusion of NILs with cytokines 
on the release of ßE-IR“
% ßE-IR release
fr. 7-13 fr. 17-23
IL -la 93.5 ± 1.6 95.5 ± 1.2
IL-lß 92.5 ± 2.9 99.4 ± 1.9
IL-2 90.8 ± 2.3 106.8 ± 2.9
IL-6 103.5 ± 2.4 96.9 ± 1.9
TNF 97.6 ± 3.4 89.4 ± 5.0
"ßE-IR release is expressed as percentage (mean ± SEM; a -  4) o f the com ­
puted basal release as described in materials and methods. Cytokines were 
added to the medium during pulse 1 (10  ng/ml) and pulse 2 ( 1(H) ng/ml).
amount of ßE-IR in the superfusates. Upon removal of 
CRH from the medium, the concentration of ßE-IR in 
the superfusates rapidly decreased and returned to 
basal levels. Superfusion of AL tissue with medium 
containing cytokine (1st pulse: 10 ng/ml, 2nd pulse: 100 
ng/ml) had no significant effect on ßE-IR release.
NIL tissue. Superfusion of NILs for 30 min with medium 
containing the ß-adrenoceptor agonist isoproterenol 
~7 M respectively 10 "6 M) induced a significant (P
Si0.01) dose-dependent increase of ßE-IR release (Is 
pulse: +62 ± 15%, 2nd pulse: +122 ± 36%; data not 
shown). Table 3 shows that superfusion of NILs for 30 
min with 10 respectively 100 ng/ml of IL-la, IL-lß, IL- 
2, IL-6 or TNF had no significant effect on ßE-IR
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Upper panel: B release from rat adrenal tissue superfused for (i h 
(black bar) with medium (□) or with medium containing 100 ng/mt 
IL-lß  ( • ) ,  IL-2 (O) or TNF (■). Thereafter superfusion was con­
tinued with initial medium for another lfi h. *P < 0.01. IL-lß vs. 
medium, from 8-24 h.
Lower panel: Continued superfusion of the same rat adrenal 
tissues as shown in the upper panel. These tissues are superfused for 
30 min (28-28.5 h; black bar) with 250 pg/ml ACTH and sub­
sequently with medium for another 3 h. Data are presented as the 
mean (+SEM ) B release of 11-12 observations.
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Adrenal tissue. The effects of superfusion of adrenal 
tissue with IL-la, IL-lß, IL-2, IL-6, TNF or ACTH on 
B release are shown in Figure 2 (lower panel). B con­
tent in the superfusates was found to be increased 
( + 195 ± 5% vs. basal release) after superfusion of 
adrenal tissue for 60 min with medium containing 125 
pg/ml ACTH. Superfusion of adrenal tissue for 1 h with 
each of the cytokines in a dose of 100 ng/ml, had no 
effect on B release. Prolonged superfusion (6 h) of 
adrenal tissue with cytokines did not induce an imme­
diate increase in B release, therefore total B release was 
calculated from 8-24 h by summation of the B content 
of each of the fractions, and subsequently compared to 
the total B release (8-24 h) after superfusion of adrenal 
tissue with medium alone. Figure 3 (upper panel) shows 
that superfusion of adrenal tissue for 6 h with IL-lß 
resulted in a significantly higher (P <  0.01) B release as 
compared to the release by the control tissues. IL-2 and 
TNF had no significant effect on basal B release. 
Superfusion of these adrenals was continued, and 
Figure 3 (lower panel) shows that exposure of the tis­
sues for 30 min to 250 pg/ml ACTH induced a signifi-
DISCUSSION
cant (all P <  0.001 vs. basal release) increase in B 
release. Superfusion of adrenal tissue with IL-lß or IL- 
2 prior to ACTH had no effect on ACTH-induced B 
release 16 h later, whereas superfusion with TNF
resulted in a reduced (—28.6 ± 10.3%; 0.01 <  P 0.05)
response of this tissue to ACTFI as compared to ACTH- 
induced B release by tissue prior superfused with only 
medium.
The present study shows that short-term (2 h) incu­
bation of rat AL cells with recombinant human (rh) IL- 
l a  or IL-l.ß in concentrations up to 1 |ig/ml did not 
significantly modify basal ßE-IR secretion. A review of 
the effects of rhIL-1 on ACTH and/or ßE release by the 
rat anterior pituitary in vitro is given in Table 4. Our 
results are in agreement with those in two other stud­
ies, which demonstrated that IL-1 has no effect on 
ACTH release by cultured rat AL cells after an incu­
bation period of 2-3 h.7-K In contrast with the lack of a
stimulatory during short-term incubation, it
8
seems that IL-1 stimulates ACTH or ßE secretion by 
rat AL cells or mouse anterior pituitary tumour cells 
(AtT-20 cells) during incubation for a more prolonged 
time (4-8 h for rat AL cells12,16 and 23-24 h10,13,14,17 for 
murine AtT-20 cells). In our study IL-1 did not modu­
late CRH-induced ßE-IR release by AL cells, which is 
in agreement with data from Berkenbosch et al.
We showed that IL-2, IL-6 and TNF were unable 
to modify basal ßE-IR release by rat AL cells during a 
2 h incubation period. Other researchers have demon­
strated that rhIL-22lJ and rhIL-614 increase basal ACTH 
release by murine AtT-20 cells, but only after 24 h of 
incubation. With regard to TNF our results are in agree­
ment with the results of other studies.6, 31 Even during 
a more prolonged incubation period (24 h), it seems 
that rhTNF is still not capable of modifying basal ACTH 
release by rat AL cells.16,32 We found that IL-2 induced
TABLE 4. A survey of literature concerning direct effects of recombinant human IL-1 on pituitary ACTH/ßE and adrenal 
B release
C rm ic iN H D ose M e t h o d E ff k c t  1REF
rhIL-lcx (MLR) 1 iiM AtT-20/DI6~l6 mouse AP tumour cells ßE T and CRHi-ßE î  aller 24 li 10
rh IL-lß (Cistron) 0,3 pM~3 nM Peri fusion rat (SD) AP ACTH T DD after 20 min pulse 11
rh IL-lß (Cistron) 10 1,’- I 0 u M Cultured rat (SD) AP cells ACTH Taller 4 h from 10 M 12
rh 11,-1 (a: MLR, ß: Otsuka) 10 >M0 " M A n -20/D 16-16 mouse AP tumour cells ßE î  alter 23 h from 10 M, CRHi-ßE T aller 23 li at Kl " M 13
rhl L-l (ex and ß: Otsuka) 10 '■‘‘-IO M AtT-20/Dlòv mouse AP tumour cells ACTH T alter 24 h from 10 " M 14
rh IL-lß (Ci enzyme) 25-100 pg/ml Peri fusion fr. iso. rat (W) AP cells ACTH T DD alter 10 min puise, CRI li-ACTI I T aller 5 min puise 15
rhl L-l (u and ß: Biogen) 0.03-30 nM Cultured rat (W) AP cells ACTH T after 8 h al 3 nM 16
rh IL-la (MLR) 10 fiM AtT-20 mouse AP tumour cells ACTH T aller 24 li 17
rhIL-l (a, ß: own product) 0.0 M  00 uM Cultured rat (CD) AP cells ACTH x. T at 100 nM, CRI li -ACTII T al lOnM U 1 |i aller 3 h 18
rhl L-l {a and ß: RPR) 10 ' -1 0  " M Perifusion rat (W) AP ACTH x, ßE x. CRHi-ACTH. -ßE x aller 50 min 19
rhIL-lu (MLR) 0.01-10 nM Cultured rat (SD) AP cells; AtT-20 cells ACTH x aller 3 h 7
rh IL-lß (gil'L Dr C. Dinarello) 0 .01-10  nM Cultured rat (W) AP cells ACTH x. CRHi-ACTH x aller 2 h 8
rhl L-l (a: Dai nippon, ß; MLR) 1-1000 U/ml Perifusion fr. iso. rat (W) AP cells ACTH x, CRHi-ACTH x aller 10 min puise 20
rh IL-lß (own product) 3.5-35 (.ig In situ perfusion rat (F) adrenal B T after c)(l min from 3.5 |ig 21
rh IL-lß (Cistron) 0.05-5 U/ml fr, iso. rat (W) AD cells B î  DD aller 24 11 from 0.05 U/ml n
rhl L-l (a: MLR, ß: Immun ex) 10 'M 0 H M Cultured rat (SD) AD cells; AD organ cultured B t  aller 24 h al 10 “ M; B T DD aller 4 h Irom 10 M 11
rh IL-lß (gift Dr S. Mizel) 10-100 U/ml Cultured rat (W) AD cells B î  DD aller 24 h from 30 U/ml 2 4
rhlL-lot(HLR) 10 m~10 HM Cultured rat (SD) AD cells B T DD aller 24 11 from 10 M 25
rhlL-lß (Calbiochem) 10 m- l0  ' M Rat (W) AD slices; fr. iso. AD cells B T after 90 min from 10 B M, ACTHi-B x, ACTHi-B x 26
rh IL-1 ß (Calbiochem) 10 '■ M fr. iso. rat (W) adrenocortical cells B x after 90 min 27
rh IL-lß (gift Dr C. Dinarello) 10 11 M Rat (SD) AD organ culture B x after 0.25-24 h 3
rh IL-lß (Immun ex, G enzyme) 6.8-54 pM Perifusion fr. iso. rat (W) AD cells B x after 5 min puise 28
Abbrevia lions: MLR: H olïtnan-La Roche; RPR; Rhône-Foulenc Rorer; ÄP: anterior pituitary; AD: adrenal; fr. iso.: freshly isolated; SD: Sprague-Dawley; W: 
Wislar; F: Fischer F344; CD: eerverian derived; Î: increase, i :  decrease, x: no effect on hormone release; DD: dose-dependent; CRHi: CRH-induced; ACTHi: 
ACTH-induced.
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a small but significant and dose-dependent increase in 
CRH-induced ßE-IR release by AL cells, whereas IL- 
6 and TNF had no such a modulatory effect. Concerning 
IL-2 and IL-6, no comparable data are available in the 
literature. With respect to TNF, our results are in line 
with those of Sharp etal.b Gaillard étal?1 demonstrated 
an inhibitory effect of TNF on CRH-induced ACTH 
release by rat AL cells, but only after prolonged (8- 
24 h) and not after short-term (2 h) incubation.
In our study, incubation of NIL cells with IL-2 for
i
2 h induced a small but significant and dose-dependent 
increase in ßE secretion, whereas the other cytokines 
tested were not effective in this respect. There are no 
data in literature regarding effects of cytokines on ßE 
secretion by the NIL of the rat pituitary gland. Very 
recently, Stepien et al?* demonstrated that IL-lß stim­
ulated proliferation of rat intermediate lobe cells.
In the present study short-term (2 h) incubation of 
isolated adrenal cells with IL-la, IL-lß, IL-2, IL-6 or 
TNF in concentrations up to 1 pg/ml had no effect on 
basal B release. Table 4 reviews the effects of rhl L-l on 
B release by rat adrenal cells or tissue in vitro. Our 
results with respect to IL-1 are in agreement with the 
results of other studies.26-27 However, one of these stud­
ies did demonstrate a stimulatory effect of IL-1 on B 
secretion by rat adrenal slices after short-term incuba­
tion (90 min) and the authors suggested that the mech­
anism underlying the direct stimulatory effect of IL-lß 
on the adrenal gland may involve the activation of an 
intraadrenal CRH-ACTH system.26 Other investiga-
showed that IL-1 dose-dependently increased 
B release by rat adrenal cells after 24 h of incubation. 
Some of these researchers found evidence for an adren-
tors 22-25
ergic •n os4M » * 4^ * »  ’ or a p roste
which IL-1 stimulated the adrenal cells to release B. Our
results concerning are in line with of
Such an inhibitory effect was also demonstrated by 
Brennan et al.35
Since paracrine effects can be missed in a cell sus­
pension system, the present study also describes the 
effects of superfusion of AL, NIL and adrenal tissue 
with cytokines on the release of ßE-IR and B. We 
demonstrated that superfusion of rat AL or NIL tissue 
with 10 respectively 100 ng/ml of IL-la, IL-lß, IL-2, 
IL-6 or TNF for 30 min had no significant effect on the 
secretion of ßE-IR. There are no other reports on 
effects of cytokines on the secretion of ßE-IR by the 
NIL using the superfusion technique. With respect to 
the AL, our results concerning I L-l are in line with 
those of Parsadaniantz ctal.S' who showed that neither 
rhIL-1 a  nor rhIL-1 ß was able to modify basal or CRH- 
induced ACTH and ßE release after 50 min of perifu­
sion of rat anterior pituitary tissue, and are in contrast 
with those of Beach et a l."  who demonstrated that per­
fusion of rat anterior pituitary tissue with IL-1 for 20
increase in ACTH 
release. With respect of IL-6 and TNF, our results con­
flict with those of other investigators, who found a stim­
ulatory effect of rhIL-633 and rhTNF30 on ACTh release 
by rat anterior pituitary tissue during 2 h of incubation. 
However, these researchers performed static incu­
bation experiments using hemi(anterior) pituitaries.
In our experiments, superfusion of rat adrenal tis­
sue with IL-la, IL-lß, IL-2, IL-6, or TNF for 60 min had 
no effect on basal B release. Our in vitro results are in
m m a
line with in vivo data by Gwosdow et al.,3 who 
strated that plasma B levels were not increased 
administration of IL-lß lo hypophyscctomized rats, 
implying that the cytokine had no detectable
mechanism by effect on the adrenal gland. On the contrary, Roh et air
found that acute administration of IL-lß into the renal 
artery of dissected and perfused rat adrenal glands 
increased adrenocortical activity as measured byBrennan et al.,35 who found no effect of rhTNF on basal 
secretion of B by adrenal cells during short-term (90 increased output of B. It has to be noted, however, that 
min) incubation. Regarding IL-2, only prolonged (24 h) these authors demonstrated stimulation of B secretion 
incubation experiments have been performed.24 In that 
study it was found that rhl L-2 had no effect on B release
after a bolus injection in the renal artery of a high dose 
(3.5 (.tg) of IL-1. In our study, prolonged superfusion of
by rat adrenal cells, * Vi"* r\ L* rat I L-2 increas B
release. With respect to rhIL-6 a stimulatory effect on 
B secretion by freshly isolated2*-34 or cultured24 rat 
adrenal cells has been demonstrated after 24 h of incu-
adren al tissue for 6 h wi th medium con taining IL- 
nilicantly increased B secretion as compared to super­
fusion of adrenal tissue with only medium, whereas I L-2
TNF were not effective in this respect. ACTH-
bation, though not after 3 or 12 h. In our study, 4t
IL-1 had no modulatory on ACTH-induced
B release, which is in agreement with the results of a 
study performed by Andreis et al.ZH We demonstrated 
in this study that neither IL-2 nor IL-6 had any modu­
latory effect on ACTH-induced B secretion.
researchers demonstrated that rhl L-224
rhIL-634 increased ACTH-induced B release by rat 
adrenal cells after .24 h of incubation. In the present 
study it is shown that TNF dose-dependently decreased 
ACTH-induced B secretion during 2 h of incubation.
induced B release was not 
prolonged superfusion of adrenal tissue with IL-1 or ÏL- 
2. Prolonged superfusion with TNF, 
inhibit ACTH-induced B release. This result is in agree­
ment with the data on simultaneous incubation of iso­
lated rat adrenal cells with both TNF and
. In this respect, it is of interest that Keri et 
strated that plasma fr
siveness of adrenocortical cells to ACTH and that 
Mathison et <i/.4,w 1 observed that
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(LPS)-stimulated macrophages release a product that 
suppresses the steroidogenic response of adrenocorti­
cal cells to ACTH. We now know that one of the 
substances, produced and secreted by macrophages 
in response to LPS, is TNF.42 So the observations of 
Keri et al.39 and Mathison et al.AÚAl might be mediated
by TNF.
In summary, the present study shows: (1) prolonged 
superfusion (6 h) of rat adrenal tissue with IL-1 
increased basal B secretion; (2) short-term (2 h) incu­
bation with IL-2 increased CRIi-stimulated ßE secre­
tion by AL cells and basal ßE secretion by NIL cells; 
(3) short-term (2 h) incubation of adrenal cells with 
TNF inhibited ACTFI-induced B release and prolonged 
(6 h) superfusion of adrenal tissue with TNF also 
reduced ACTH-induced B release; (4) in all other 
experiments IL-la, IL-lß, IL-2, IL-6 and TNF did not 
modify basal or CRH-induced secretion of ßE and basal 
or ACTH-induced secretion of B. It has to be stressed, 
however, that the effects of cytokines on hormone 
secretion by the pituitary or adrenal gland were small 
and only found during incubation with high doses of 
cytokines and/or prolonged incubation. Our data make 
it unlikely that the acute elevation of plasma ACTH and 
B levels, seen after bolus injections of these cytokines 
in vivo, are mediated by a direct action of these 
cytokines on the pituitary and/or adrenal gland.
Animals
MATERIALS AND METHODS
Test materials
Human adrenocorticotropic hormone1 (ACTH) was 
obtained from the National Institute for Biological Standards 
and Control (NIBSC, Potters Bar, UK; MRC standard 
74/555). Rat corticotropin-releasing hormone (CRH) was 
obtained from Byk (Zwanenburg, The Netherlands) and iso­
proterenol (isoprenalini sulfas) was obtained from OPG 
(Utrecht, The Netherlands). Dopamine HC1 was obtained 
from Sigma Chem ical C om pany (St. Louis, M O). 
Recombinant human interleukin la  (IL-la; specific activity 
(S.A.) 3.10s U/mg protein, endotoxin contamination (E.C.) 
<1 endotoxin unit/mg protein) was a generous gift of Dr P. 
Lomedico (Hoffman-La Roche, Nutley, NJ), recombinant 
human interleukin- Iß (IL-1 ß; S.A. 2.5.IO7 U/mg protein, E.C. 
<1.2 ng/mg protein) was kindly provided by Dr A. Shaw 
(Biogen, Geneva, Switzerland), recombinant human tumour 
necrosis factor-a (TNF; S.A. 6.107 U/mg protein, E.C. <1  
endotoxin unit/mg protein) was obtained from Boehringer 
(Ingelheim, Germany), recombinant human interleukin 2 
(IL-2; S.A. 1.5.10° U/mg protein, E.C. < 7  endotoxin units/mg 
protein) was kindly provided by Dr A. Galazka (Glaxo, 
Geneva, Switzerland) and recombinant human interleukin 
6 (IL-6; S.A. IO6 U/mg protein, E .C  <1.2 ng/mg protein) 
was generously donated by Dr L. Aarden (Central 
Laboratory of Blood Transfusion •vice of The
Male albino Wistar rats (Cpb: W U) weighing 180-240 g 
were obtained from the local breeding facility on the day
the experiment. The animals were then housed 
overnight, four to a cage, in a room adjacent to the animal 
home in which the decapitations were to be performed. In all 
experiments the rats were killed by decapitation between 0930 
and 1030 h.
Cell suspension experiments
Pituitary cells. Immediately after decapitation the skull was 
opened, the brain taken out and the pituitary quickly removed 
from the cranium. The anterior lobe (AL) and the neuroint­
ermediate lobe (NIL) were carefully separated from each 
other and the A L  was cut in about 8-10 pieces. AL and NIL  
tissues were separately placed in a flask filled with 10 ml 
Earle’s Balanced Salt Solution (EBSS, 116 mM NaCl, 5.36 
mM KC1,1.15 mM N aH 2P 0 4.2H20 ,  0.81 mM M gS04.7H20 ,  
26 mM NaHCO.i, 1.79 mM CaCl2.2H20  and 5.0 mM glucose. 
H 20 )  containing benzylpenicillin (15 |ig/ml; Sigma), strepto­
mycin (25 jig/ml; Merck, Darmstadt, Germany), ascorbic acid 
(30 fig/ml; Merck) and 0.25% (w/v) trypsin (type II; Sigma). 
H ie cells were dispersed at 37°C by mild mechanical agita­
tion in a shaking waterbath. During dispersion the cells were 
gassed with carbogen (95% O2/5% C 0 2). After 20 min incu­
bation the supernatant was decanted into a 10 ml plastic cen­
trifuge tube and retained at room temperature. A  further 10 
ml of the EBSS/trypsin solution was added to the pituitary 
fragments. A  total of 3 X 20 min cell harvests were collected. 
The supernatants were pooled and centrifuged at room tem­
perature for 40 min (200 X g). The pellet, consisting of iso­
lated cells, was resuspended and diluted in EBSS buffer 
containing bovine serum albumin (BSA,0.25% (w/v); O H R D  
20/21, Hoechst-Behring, Marburg, Germany), ascorbic acid 
(30|ig/ml), the antibiotics, aprotinine (100 KIE/ml; Bayer AG, 
Leverkusen, Germany), bacitracin (100 jiig/ml; Sigma) and 
lima bean trypsin inhibitor (66 |ig/ml; type I-S|, Sigma) 
(EBSS4) to a concentration of about 50 000 cells per 800 (il 
medium. Cell suspensions were preincubated for 90 min at 
37°C, and subsequently 200 jllI of EBSS ' solution containing 
CRH (5.10 10 M), cytokine (IL-la, IL-lß, IL-2, IL-6, or TNF; 
1 pg/ml-1 ng/ml) or CRH in combination with cytokines, was 
added. Incubation was continued for another 120 min. NIL 
cells were only incubated with cytokines (IL -la , IL-lß, IL-2, 
IL-6, or TNF; 1 pg/ml-1 (ig/ml). Incubation was terminated 
by cooling on ice and the supernatant was subsequently col­
lected by centrifugation (15 min, 1000 x  g) and the medium 
assayed for ßE-IR within 24 h.
Netherlands Red Cross, Amsterdam, The Netherlands). All 
chemicals used were of analytical grade.
Adrenal cells. Rat adrenal cells were isolated and incubated 
according to a method extensively described by Goverde 
et al.3f> Isolated rat adrenal cells were incubated for 2 h with 
different peptides (ACTH 25 pg/ml; cytokines 1 pg/ml-1 
(a.g/ml; ACTH and cytokines) dissolved in Krebs-Ringer- 
Bicarbonate buffer containing 0.2% glucose, 0.5% BSA and 
7.65 mM Ca2+ (KRBGACa). Incubation was stopped by cool­
ing on ice and all samples were stored at 4MC. Corticosterone 
production was measured the next day.
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Cell viability. After preparing the cell suspensions, cell via­
bility was tested by mixing an aliquot of the cell suspension 
with an equal volume of trypan blue (BDH, 0.1% (w/v) in 
0.9% NaCl). In all experiments, more than 95% of the cells 
excluded the dye. Responsiveness of the cells was tested by 
incubation of AL cells with CRH (5.10 1(1 M), NIL cells with 
dopamine (10~h M) and adrenal cells with ACTH (25 pg/ml).
Hormone measurement
ß-endorphin-like-im m unoreactivity  
measured by radioimmunoassay (RIA) as described by 
Sweep et al.?1 using an antiserum kindly provided by Dr V.
E-IR) was
M. Wiegant, Rudolf Magnus (UtreclU, The
Netherlands). B was measured lluorome tricall y, as described 
by Goverde el al.M’
Superfusion experiments
Pituitary tissue. Dissected ALs (quartered) and NILs (intact) 
were transferred to a superfusion apparatus (2 ALs or 2 NILs 
per chamber). The tissues were superfused continuously with 
earbogenated KRB-buffer (118 mM NaC l,4.85 mM KC1,1.15 
mM KH2P 0 4, 1.15 mM M g S 0 4.7H20 ,  25 mM NaHCO* and 
1.25 mM C aC k2H 20 )  supplemented with BSA (0.5%; Sigma 
fraction V), ascorbic acid (0.1 mM) and glucose (11.1 mM) 
(medium). The flow rate was kept constant at 0.1 ml/min using 
a Gilson Mini-puls 3 peristaltic pump (Meyvis, Bergen Op 
Zoom, The Netherlands). The temperature of the superfu­
sion chambers and media was kept constant at 37°G In these 
experiments, the tissues were first superfused with medium 
for 180 min to allow the release of ßE-IR to reach a rather 
stable level. Thereafter superfusion was continued for240 min 
and fractions (fr.) were collected in ice-chilled tubes every 10 
min. Pituitary tissues were superfused twice for 30 min ( l sl 
pulse: fr. 7-9, 2nd pulse: fr. 17-19) with medium containing 
cytokines (IL-la , IL-lß, IL-2, IL-6 or TNF; Impulse: 10 ng/ml; 
2nd pulse: 100 ng/ml), CRH (ALs; 1st pulse: 5 .1()'"1(IM; 2ml pulse: 
5.1(r‘; M) or isoproterenol (NILs; 1st pulse: 10"7 M; 2nd pulse: 
10"h M). 100 |iil aliquots of the superfusates were taken for 
determination of ßE-IR.
Adrenal tissue. Dissected adrenals were freed of fat, cut in 
about 16 pieces and transferred to a superfusion apparatus ( 1 
adrenal/chamber). The adrenal tissue was Irrst superfused for 
30 min with medium to allow the release of B to reach a rather 
stable level. From then on 15 min fractions were collected 
in ice-chilled tubes for 5.5 h. During this period the adrenal
for 1 h (fr. 11-14) with medium1P was super
containing cytokines (IL-la , IL-lß, IL-2, IL-6 or TNF; 100 
ng/ml) or ACTH (125 pg/ml). In order to investigate whether 
prolonged exposure of adrenal tissue to cytokines had any 
effect on basal or ACTH-induced B release, rat adrenal tis­
sues were superfused in other experiments for 6 h with
Calculations and statistical analysis
Cell suspension experiments. ßE-IR and B release is expressed
as percentage of basal hormone release by AL i N I L
incubated with E B SS1 solution (control) respectively by 
adrenal cells incubated with KRBGACa buffer (control). In 
case of incubation of adrenal cells with cytokines in combina­
tion with ACTH (25 pg/ml), B release is expressed as per­
centage of the release during incubation of cells with ACTH 
only. Data were statistically analysed for a dose-response rela-
ustng a ar regression
^arithm of the dose of the used peptide.
% release = (X| + a> (CRH) + a.^log cytokine)
+ a 4(CRH).(log cytokine)
Here ai is an estimate of the effect of incubation of A L  or 
NIL cells with EBSS4 solution respectively incubation of 
adrenal cells with KRBGACa buffer or an estimate of the 
effect of incubation of adrenal cells with 25 pg/ml ACTH only, 
a-, is an estimate of the effect of incubation of AL cells with 
CRH alone, ccj is an estimate of the dose-response relation­
ship for the effects of incubation of AL, NIL or adrenal cells 
with cytokines only or for the effects of incubation or adrenal 
cells with cytokines in combination with ACTH. a,i is an esti­
mate of the dose-response relationship for the effects of incu­
bation of AL cells with cvtokines in combination with CRH.
for a significant dose-response implies 
whether the corresponding a ’s are equal to zero. By way of 
precaution, differences are considered to be statistically sig­
nificant if P <  0.01.
Superfusion experiments. The spontaneous rate of release of 
-IR and B was not identical for the different AL, NIL or 
adrenal tissues within the same experiments. To compare 
results between the superfusion chambers, the total amount
of drug-induced ßE-IR (AL and NIL: fr. 7..13 and IV. 17-23)
medium containing 100 ng/ml o f  IL-lß, IL-2orTN Fand later or B (adrenal: fr. 12-21; prolonged adrenal superfusion: fr. 
for 30 min with 250 pg/ml ACTH. Control tissues were super- 15-20 (28.5-31 h)) release was summed and expressed as per
j  4 * j 1  i  J  i  1 1  l i  r i " * !  f i l l *fused continuously with medium alone. During these pro- centageofthe calculated basal release. The area under the line
experiments medium was linking the means of the ßE-IR or B content of the two frac-ad renal
supplemented with benzylpenicillin (100 fig/ml), strepto- tions immediately preceding (ßE-IR (AL and NIL): Pl pulse: 
myein (100 ng/ml), aprotinine (20 KIE/ml) and bacitracin (30 fr. 5-6, 2Md pulse: fr. 15-16; B (adrenal: fr. 10-11 ; B (prolonged
idrenal superfusion): 2ml pulse: fr. 13—14 (26-28 h)) and thefig/ml) (medium4). The flow rate was kept constant at 2 ml/h.
to basal levels had occurred (ßE-IR (AL and NIL): P1 
fr. 14-15, 2nd pulse: fr. 24; B (adrenal): fr. 22; B (prolonged 
adrenal superfusion): 2nd pulse: fr. 21 (31.5 h)) was taken as
B release was allowed to reach rather stable levels to 2 h and first one or two fractions in which stabilization of the release
fractions were collected every 2 h for 28 h. Adrenal tissue was 
superfused for 6 h (fr. 4 -6 )  with m edium 1 alone or with 
m edium 1 containing 100 ng/ml of IL-lß, IL-2 or TNF. After 
28 h of superfusion the responsiveness of the adrenal tissue
was tested by superfusion for 30 min with m edium 1 contain­
ing 250 pg/ml ACTH. From then on 30 min fractions were 
collected for 3.5 h. Total superfusate fractions were taken for 
B determination.
basal release. Data concerning différences between the drug- 
induced hormone release and the computed basal release were 
statistically analysed by a paired t-lest after logarithmic trans­
formation of the doses. By way of precaution, differences are 
considered to be statistically significant if p < 0 .0 1 .
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